Skip to main content
Deutsch

Clinical & Epidemiological Science Unit

Director: Assoc. Prof. Peter Mandl
  1. Department of Medicine III
  2. Our departments
  3. Rheumatology
  4. Research
  5. Clinical & Epidemiological Science Unit

Latest Research

Management strategies in rheumatoid arthritis. Nat. Rev. Rheumatology. December 2024

Humoral and cellular response to the third COVID-19 vaccination in patients with inborn errors of immunity or mannose-binding lectin deficiency : A prospective controlled open-label trial. Wien Klin Wochenschr. November 2024

Self-Monitoring Practices and Use of Self-Monitoring Technologies by People with Rheumatic and Musculoskeletal Diseases: An International Survey Study. Healthcare (Basel). October 2024

Role of rheumatoid arthritis registries worldwide: What have they taught us? Best Pract Res Clin Rheumatol. Ocotber 2024

Tendon involvement and its association with pain and hand function in patients with osteoarthritis of the hand. Rheumatology (Oxford). August 2024

Systematic literature review to inform the EULAR recommendations for the use of imaging in crystal-induced arthropathies in clinical practice. Ann Rheum Dis. August 2024
Watch our dedicated video here.

Research Group of Helga Lechner-Radner

To the Research Group

Research Group of Peter Mandl

We perform and interpret imaging studies encompassing all manifestations of rheumatic and musculoskeletal diseases and develop new diagnostic and therapeutic methods targeting fibroblasts.

To the research group

Research Group of Clemens Scheineker

Autoimmunity and Immunodeficiency

We study, treat and manage patients with immune mediated inflammatory diseases as well as patients with primary or secondary immunodeficiencies.

To the Research Group

Research Group of Daniela Sieghart

Biomarkers in rheumatic disorders

We study autoantibodies as potential biomarkers for diagnosis, management and prognosis of rheumatic conditions.

To the Research Group

Research Group of Paul Studenic

We try to understand the validity of outcomes used in measuring disease activity, progression, quality of life and the interaction of patients with the health care system.

To the Research Group